Pacamaman, Hanna .
HRN: 24-75-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2024
CEFUROXIME 1.5GM (VIAL)
03/13/2024
03/13/2024
IV
1.5g
On Call To OR
Stat Pelvic Lap
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes